http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104203169-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F6-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F6-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 |
filingDate | 2011-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104203169-B |
titleOfInvention | Comprising the pessary of the reagent of the release of meloxicam and the described active component of adjustment, it can be used as the contraceptive used continuously in women |
abstract | The present invention relates to the pessary of sustained release, it comprises the reagent of meloxicam and the release regulating described active component, for instance PVP K-30, and it discharges described active component at least 90 days, and it can be used as the contraceptive used continuously in women.Described pessary preferably comprises the meloxicam of 5 weight % to 30 weight % for the gross weight of said preparation. |
priorityDate | 2011-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 123.